학술논문
Deucravacitinib, a selective, allosteric tyrosine kinase 2 inhibitor, in scalp psoriasis: A subset analysis of two phase 3 randomized trials in plaque psoriasis
Document Type
Article
Author
Source
In: Journal of the American Academy of Dermatology . (Journal of the American Academy of Dermatology, April 2024, 90(4):775-782)
Subject
Language
English
ISSN
10976787
01909622
01909622